653 Results

People

  1. Scher
    Scher
  2. Bajorin
    Bajorin
  3. Herr
    Herr
  4. Motzer
    Motzer
  5. Bosl
    Bosl
  6. Kris
    Kris
  7. Yahalom
    Yahalom
  8. Kelsen
    Kelsen
  9. Sheinfeld
    Sheinfeld
  10. Straus
    Straus

Groups

  1. Department of Medicine (361)
  2. Solid Tumor Oncology Division (271)
  3. Genitourinary Oncology Service (161)
  4. Survivorship Research (149)
  5. Surgery (135)
  6. Hematologic Malignancies, Division of (94)
  7. Urology (91)
  8. Center for Hematologic Malignancies (83)
  9. Lymphoma (65)
  10. Radiation Oncology, Department of (41)
  1. "vinblastine"
Formats
  1. Journal Article (613)
  2. Conference Paper (17)
  3. Review (8)
  4. Editorial (6)
  5. Meeting Abstract (5)
  6. Research Letter (2)
  7. Book Section (1)
  8. Correspondence (1)
Groups
  1. Department of Medicine (361)
  2. Solid Tumor Oncology Division (271)
  3. Genitourinary Oncology Service (161)
  4. Survivorship Research (149)
  5. Surgery (135)
  6. Hematologic Malignancies, Division of (94)

More Groups

People
  1. George Bosl (71)
  2. Howard Scher (59)
  3. Dean Bajorin (55)
  4. Harry Herr (53)
  5. Robert Motzer (53)
  6. Mark Kris (38)

More People

Years
  1. 2025 (7)
  2. 2024 (11)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (6)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (64)
  2. Cancer (38)
  3. Seminars in Oncology (34)
  4. Journal of the National Comprehensive Cancer Network (28)
  5. Journal of Urology (18)
  6. Annals of Oncology (12)

More Publications

Publishers
  1. Elsevier Inc. (109)
  2. American Society of Clinical Oncology (65)
  3. Wiley Blackwell (56)
  4. Elsevier Science, Inc. (50)
  5. Lippincott Williams & Wilkins (32)
  6. Springer (30)

More Publishers

Results (653)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): Phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
    Journal Article

    Rubinstein, P. G.; Moore, P. C.; Bimali, M.; Lee, J. Y.; Rudek, M. A.; Chadburn, A.; Ratner, L.; Henry, D. H.; Cesarman, E.; DeMarco, C. E.; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • Positron emission tomography-adapted therapy in bulky stage I/II classic Hodgkin lymphoma: CALGB 50801 (Alliance)
    Journal Article

    LaCasce, A. S.; Dockter, T.; Ruppert, A. S.; Kostakoglu, L.; Schöder, H.; Hsi, E.; Bogart, J.; Cheson, B.; Wagner-Johnston, N.; Abramson, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Systemic therapy in bladder preservation
    Review

    Girardi, D. M.; Ghatalia, P.; Singh, P.; Iyer, G.; Sridhar, S. S.; Apolo, A. B.
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save
  • ALK-positive histiocytosis: A new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
    Journal Article

    Kemps, P. G.; Picarsic, J.; Durham, B. H.; Hélias-Rodzewicz, Z.; Hiemcke-Jiwa, L.; van den Bos, C.; van de Wetering, M. D.; van Noesel, C. J. M.; van Laar, J. A. M.; Verdijk, R. M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: An adaptive choice-based conjoint analysis
    Journal Article

    Knoerl, R.; Berry, D.; Meyerhardt, J. A.; Reyes, K.; Salehi, E.; Thornton, K.; Gewandter, J. S.
    Supportive Care in Cancer (2022)

    Fulltext@MSK | Save
  • Reply to S. Zhang
    Correspondence

    Lattanzi, M.; Funt, S. A.; Rosenberg, J. E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Overall survival with brentuximab vedotin in stage III or IV Hodgkin's lymphoma
    Journal Article

    Ansell, S. M.; Radford, J.; Connors, J. M.; Długosz-Danecka, M.; Kim, W. S.; Gallamini, A.; Ramchandren, R.; Friedberg, J. W.; Advani, R.; Hutchings, M.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • The ABVD’s of cooperative trials in pediatric Hodgkin lymphoma: The India experience
    Editorial

    Rodriguez-Hernandez, A.; Giulino-Roth, L.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: A detailed analysis from the phase III ECHELON-1 study
    Journal Article

    Evens, A. M.; Connors, J. M.; Younes, A.; Ansell, S. M.; Kim, W. S.; Radford, J.; Feldman, T.; Tuscano, J.; Savage, K. J.; Oki, Y.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Rosai–Dorfman–Destombes disease of the nervous system: A systematic literature review
    Review

    Nasany, R. A.; Reiner, A. S.; Francis, J. H.; Abla, O.; Panageas, K. S.; Diamond, E. L.
    Orphanet Journal of Rare Diseases (2022)

    Fulltext@MSK | Save